feed,title,long_url,short_url
Benzinga,"LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships",https://benzinga.com/analyst-ratings/analyst-color/24/10/41583181/lenz-therapeutics-investigational-drug-for-age-related-blindness-aces-pivotal-china,https://da.gd/3KqX
